Cordlife Group Limited (SGX:P8A)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.151
-0.029 (-16.11%)
Apr 29, 2026, 1:58 PM SGT
0.00%
Market Cap 46.14M
Revenue (ttm) 38.85M
Net Income (ttm) -12.64M
Shares Out 256.31M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,000
Average Volume 29,765
Open 0.151
Previous Close 0.180
Day's Range 0.151 - 0.151
52-Week Range 0.121 - 0.330
Beta 0.65
RSI 69.52
Earnings Date May 25, 2026

About Cordlife Group

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test ... [Read more]

Industry Medical - Diagnostics & Research
Sector Healthcare
Founded 2001
Employees 538
Stock Exchange Singapore Exchange
Ticker Symbol P8A
Full Company Profile

Financial Performance

In 2025, Cordlife Group's revenue was 38.85 million, an increase of 40.53% compared to the previous year's 27.65 million. Losses were -12.64 million, -33.06% less than in 2024.

Financial Statements

News

There is no news available yet.